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Diabetic mastopathy (DMP) is an uncommon collection of clinical, radiological, and histological features, classically described in
premenopausal women with long-term insulin-dependent diabetes mellitus. This entity can mimic breast carcinoma, but, in the appropriate
clinical and imaging setting, the diagnosis can be made by core biopsy, avoiding unnecessary surgeries.
We report the case of a 34-year-old female, with a 12-year history of type 1 diabetes, who presented with bilateral breast lumps.
Mammography, ultrasonography, and magnetic resonance imaging could not exclude the suspicion of malignancy, and a core biopsy was
performed showing the typical histologic features of DMP.
The literature is briefly reviewed.
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Diabetic mastopathy (DMP) is a collection of clinical,
radiological, and histological features found in dense fibrous
masses of the breast first described by Soler and Khardori [1]
in 1984.
Since then, further studies have elucidated the histopath-
ologic features of this unusual fibroinflammatory lesion that
represents less than 1% of benign breast lesions [2].
The disease is associated with long-standing type 1
insulin-dependent diabetes mellitus (IDDM) but has also
been reported in other autoimmune disorders and in type 2
diabetes mellitus [3,4].
These patients present with solitary or multiple palpable,
hard, painless, and irregular masses. Mammography usually
discloses only dense glandular tissue, and ultrasound shows
irregular, diffuse shadowing zones, sometimes hypoechoic
attenuating nodules [5,6]. These clinical and imaging⁎ Corresponding author. 1070-234 Lisbon, Portugal.
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http://dx.doi.org/10.1016/j.clinimag.2012.01.003findings are inconclusive, and these lesions are often
misdiagnosed as breast carcinomas.
The recognition of this rare but benign disease is crucial
to avoid surgical biopsies which are not necessary [5].2. Case report
The patient described is a 34-year-old female, with a 12-
year history of type 1 IDDM, who presented with bilateral
breast lumps. There was no associated pain, but she noticed
an increasing breast discomfort.
She was being treated for type 1 diabetes for the last
12 years and had retinopathy as secondary complication
of diabetes.
Menarche had occurred at age 13, with regular menstrual
cycles. For the last 12 months she used oral hormone
contraceptive. She had two preterm vaginal deliveries and
breastfeed for 6 months. Personal (besides IDDM) and
familiar medical histories were unremarkable.
Physical examination revealed bilateral hard, irregular,
mobile, painless nodules in the upper quadrants of the left
Fig. 2. Ultrasonographical image of the left breast reveals an irregular
hyperechoic mass with intense posterior acoustic shadowing.
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There was no nipple discharge, skin abnormalities, or
axillary lymphadenopathy.
Mammography revealed bilateral heterogeneous dense
breast parenchyma, BI RADS 4 of the ACR, with a nodular
pattern, more pronounced in the upper quadrants. There were
no suspicious microcalcifications, masses, or architectural
distortions (Fig. 1).
The left breast ultrasound examination showed a
hyperechoic mass with irregular contours, measuring 5×2.5
cm associated with intense posterior acoustic shadowing
(Fig. 2).
A magnetic resonance imaging (MRI) was performed (1.5
T Sonata scanner, from Siemens) with the following pulse
sequences: T1-weighted imaging in the axial plane, T2-
weighted and T2-weighted fast spin-echo imaging in the axial
and sagittal plane, and dynamic 3D T1-weighted gradient-
echo MRI, before and after the intravenous administration of
gadopentetate dimeglumine (Magnevist 0.1 mg/kg), with five
contrast-enhanced sequences being performed. Postproces-
sing analysis with subtraction images, multiplanar recon-
struction in the axial plane, maximum-intensity-projection,
and revision on a 3D workstation were also performed.
MRI detected symmetric heterogeneous low signal
intensity images on T1 and T2. Subtraction images after
contrast (gadolinium) intravenous administration showed
poor and diffuse enhancement with no focal or nodular
suspicious enhancement. Cinetic levels were nonspecific
with late bilateral enhancement patterns (heterogeneous) due
to parenchymal functional tissue (Fig. 3). The findings
suggested a typically benign gradual type dynamic curve.Fig. 1. (A, B) Bilateral mediolateral mammograms (60°). (A) Right breast.
(B) Left breast. Dense heterogeneously fibroglandular pattern of breast
parenchyma, with a nodular pattern (BI RADS 4 of the ACR).A biopsy under ultrasound guidance was performed.
Histologic evaluation revealed a dense stromal fibrosis and
some periductal lymphocytic infiltration without any evi-
dence of atypia or malignancy suggestive of DMP (Fig. 4).
The patient remains in clinical and imaging surveil-
lance, and currently has a follow-up of 2.5 years with a
stable condition.3. Discussion
Diabetic mastopathy (DMP) is a rare entity of self-
limiting fibroinflammatory disease of the breast associated
with type 1 diabetes mellitus. The prevalence of DMP has
been found to be less than 1% of benign breast diseases, but
can range from 0.6% to 13% in type 1 diabetic women [1,2].
Most published reports of DMP are of premenopausal
women with long-standing type 1 IDDM, as in the case
presented. Most patients with DMP also have complications
arising from diabetes such as retinopathy, neuropathy, and
nephropathy [1,5].
This condition has also been described in type 2 diabetes
and in patients with other endocrine disease, especially
thyroid diseases. Rarely, it can also occur in men with long-
standing diabetes [5,7].
Clinical findings include hard, irregular, easily movable,
painless breast masses. It can be solitary or multiple,
unilateral or bilateral (in about 60% of cases), especially in
the subareolar region. These characteristics raised the
suspicion of carcinoma [1,2,8]. Our patient had a typical
clinical presentation with bilateral masses.
Mammographic features usually show a localized in-
creased density in the glandular pattern, with no distinct
masses, spiculation, or calcifications. Strong acoustical
Fig. 3. (A–D) Axilal MR images. (A, B) Axial T1- and T2-weighted native
sequences—low signal intensity images, symmetric features. (C) Axial T1-
weighted image, post-gadopentetate dimeglumine (Gd); subtraction 1′
shows no focal or nodular suspicious enhancement. (D) Axial T1-weighted
image, post Gd; subtraction 5′ shows late bilateral enhancement (hetero-
geneous) due to parenchymal functional tissue.
Fig. 4. Photomicrograph of core biopsy. Periductal lymphocytic
infiltrate and stromal fibrosis (hematoxylin–eosin staining, original
magnification ×20).
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sonography, consistent with our case report. Attenuation
increases due to the fibrotic nature of the masses [2,8].
Recent literature proposes that MRI features of DMP
show the absence of enhancing mass with nonspecific
parenchymal enhancement as opposed to carcinoma in
which an avidly enhancing focal mass with irregular margins
may be present. However, clinical and radiographic features
are not specific to DMP and may be difficult to differentiate
from malignancy without biopsy [6,9,10].Logan and Hoffman [11] have advocated the use of fine
needle aspiration biopsy cytology in the diagnosis of DMP.
They stated that the firm resistance experienced during the
back-and-forward motion of the needle is stronger than that
of other benign and malignant breast conditions; hence, this
could be a clue to the diagnosis of DMP. Cytology usually
yields benign ductal epithelium with a moderate amount of
peculiar-appearing, dense, hyalinised fibrous tissue. Unfor-
tunately, DMP contains little cellular material, making
cytological diagnosis difficult.
Histologically, DMP lesions are composed of dense
stromal keloid-like fibrosis containing little or no adipose
tissue or cellular material. Furthermore, focal perivascular,
periductal, and/or perilobular lymphocytic infiltrations with
mature B-cell predominance are commonly seen. Epithelioid
fibroblasts in the interlobular stroma are also frequently
observed [6,8,11]. This correlates with our patient.
The awareness of the clinical presentation, the imaging,
and cytological features are sufficient to diagnose DMP
without the need for an excision biopsy. DMP tends to recur
after surgical excision, in the same location, and involves
more breast tissue than the preceding lesion, and therefore
surgical biopsy should not be considered. In cases where the
cytological diagnosis is difficult, core needle biopsy under
ultrasound guidance avoids unnecessary surgical procedures
that may exacerbate the condition [2,5].
The pathogenesis of DMP is not completely understood,
but several theories have been proposed considering a
multifactorial etiology. Many researchers suggest a role for a
secondary autoimmune reaction to abnormal extracellular
matrix accumulation that is a manifestation of the effects of
hyperglycemia on connective tissue. Hyperglycemia induces
glycosylation, increased intermolecular cross-linkage, and
matrix expansion that is altered in quantity and quality and
resistant to degradation. The accumulation of abnormal
matrix and advanced glycosylated end products acts as neo-
antigens and triggers an autoimmune response with B-cell
proliferation and autoantibody production. Subsequent
macrophage-mediated advanced glycosylation end-product
removal and cytokine release may act as growth factors and
induce additional matrix expansion and proliferation of
collagen [2–4].
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in the breast are similar to that of other diabetic
complications, it is not unlikely that some patients with
DMP will have thyroid, eye, and joint involvement due to
their long-standing insulin-dependent diabetes [8].
Diabetic mastopathy has also been described in patients
with type 2 diabetes mellitus who had been exposed to
exogenous insulin. This suggests that the exogenous insulin
may be related to its development. This may be due to
inflammatory or immunologic reaction to the insulin, the
vehicle, or a contaminant in the vehicle [4,8].
The publications on DMP have been few and there is no
standard protocol for the long-term management of these
patients. If DMP is confirmed on histology, most reports
recommend yearly physical examination, mammographic,
and ultrasonographic examinations. However, as it has been
noted that the number and size of DMP usually increase as
the patient grows older, it is suggested that serial fine needle
aspiration cytologies or core biopsies are performed on these
new lesions to ensure that they are not malignant lesions. It is
not recommended to perform open excisional biopsy if
clinical and radiological features are suggestive of DMP [6].
There have been no reported cases of malignancy arising
from DMP to the present date, and there has been one
reported case of regression [8].
In conclusion, recognizing DMP requires awareness of
the existence of this entity and a careful correlation of the
patient's clinical history with the physical, radiological, and
pathological examinations. DMP should be considered in thedifferential diagnosis of breast cancer but it is not a
premalignant disease. As the disease can be managed
conservatively but may recur, an accurate diagnosis is
essential to avoid unwanted multiple surgical biopsies [3,6].
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